Immune Pharmaceuticals Inc (NASDAQ:IMNP)

North American company

Market Info

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info

  • Market Cap$5.930m
  • SymbolNASDAQ:IMNP
  • IndustryHealthcare
  • SectorDrug Manufacturers - Major
  • Currency
  • ISINUS45254C2008

Company Profile

Immune Pharmaceuticals Inc is a biopharmaceutical company developing therapeutic agents for the treatment of immunologic and inflammatory diseases. The company's bertilimumab, a first-in-class human monoclonal antibody that binds eotaxin-1.